Testing effectiveness (Phase 2)Study completedNCT04371367
What this trial is testing
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )
Who this might be right for
COVID
Assistance Publique Hopitaux De Marseille 208